Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison

Trial Profile

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Jul 2009

At a glance

  • Drugs Etanercept; Sulfasalazine
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 01 Jul 2009 Results have been reported in the Annals of the Rheumatic Diseases.
    • 11 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top